Henn Matthew R 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Henn Matthew R（CIK 1767321）在 1 家公司共报告 16 笔 SEC Form 4 内部人交易（最近一笔 2026-08-18）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-18 | Seres Therapeutics, Inc. (MCRB) | President and Chief Scientific Officer | 买入 | 238 | $0 |
| 2026-08-18 | Seres Therapeutics, Inc. (MCRB) | President and Chief Scientific Officer | 卖出 | 81 | $369 |
| 2026-05-19 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 买入 | 238 | $0 |
| 2026-05-19 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 卖出 | 77 | $580 |
| 2026-02-18 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 买入 | 239 | $0 |
| 2026-02-18 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 卖出 | 89 | $754 |
| 2025-11-18 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 买入 | 3,998 | $0 |
| 2025-11-18 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 买入 | 140 | $0 |
| 2025-11-18 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 买入 | 98 | $0 |
| 2025-11-18 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 卖出 | 1,257 | $21,746 |
| 2025-08-19 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 买入 | 141 | $0 |
| 2025-08-19 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 买入 | 97 | $0 |
| 2025-08-19 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 卖出 | 73 | $1,215 |
| 2025-05-19 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 买入 | 140 | $0 |
| 2025-05-19 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 买入 | 98 | $0 |
| 2025-05-19 | Seres Therapeutics, Inc. (MCRB) | Chief Scientific Officer and EVP | 卖出 | 77 | $561 |
来源：SEC Form 4 申报文件 · 截至 2026-08-18